Skip to main content
European Commission logo print header

Center of Excellence in Advanced Pharmaceutical Technologies

Descripción del proyecto

La República Checa crea el Centro Farmacéutico de Excelencia en Tecnología Avanzada

Los ácidos nucleicos, incluidos el ADN y el ARN, presentan posibilidades apasionantes para el tratamiento de numerosas enfermedades, sin olvidar su uso en vacunas como sucedió durante la pandemia de la COVID-19. Su transporte dirigido a células y tejidos específicos sigue siendo un reto. La Facultad de Farmacia de la Universidad Masaryk (República Checa) está perfectamente posicionada para afrontar este desafío. En el proyecto ExcellPharmTech, financiado con fondos europeos, se establecerá una cátedra del Espacio Europeo de Investigación para cubrirá una cátedra del Espacio Europeo de Investigación para crear el Centro Farmacéutico de Excelencia en Tecnología Avanzada. Así, se impulsará la investigación y el desarrollo para lograr la administración selectiva de ácidos nucleicos a células diana y desarrollar asociaciones estratégicas para una traslación más rápida de los fármacos avanzados a la práctica clínica.

Objetivo

Masaryk University (MU) is the second-largest university in the Czech Republic located in Brno. Thanks to the ESIF funding, MU was able to acquire top research infrastructure attracting talented researchers who gradually built the position of the MU as the top regional hub for education, research, and innovation.
To further exploit this potential, the management structures and processes of the university must thoroughly implement the European Research Area (ERA) Priorities. As an outstanding researcher/innovator can have a decisive and positive impact on the culture and performance of any institution, MU will recruit a world-class research manager as an ERA Chair for its newly-established Faculty of Pharmacy.
The Faculty of Pharmacy (MUNI Pharm) is, besides others, focused on the development of advanced drug formulations and molecular biology techniques. The ERA Chair will intensify the research and development of advanced drug formulation and nanotechnologies to open new opportunities to intensify MUNI Pharm research capacities in the field of pharmacy and develop strategic partnerships with the application sphere and public sector for faster translation of the advanced drugs into clinics.
The recruitment of leading scientist will enforce the connection of the MUNI Pharm to research structures of MU, and the ERA Chair will make a bridge in the formation of unique education and research facility at one place titled MUNI BioPharma Hub, supported from National Recovery Plan (part of RRF – Recovery and Resilience Facility, NextGeneration EU).
To solve the targeted delivery and transportation of nucleic acids into target cell environment, the MUNI Pharm will establish an interdisciplinary center of excellence (Pharma Center of Excellence in Advanced Technology) with prof. David Oupický as its leader. The creation of an international ERA Chair team will ensure a successful establishment of the center combining excellent research, high level education and top innovations.

Régimen de financiación

CSA - Coordination and support action

Coordinador

Masarykova univerzita
Aportación neta de la UEn
€ 2 499 364,00
Dirección
Zerotinovo namesti 9
601 77 Brno
Chequia

Ver en el mapa

Región
Česko Jihovýchod Jihomoravský kraj
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 2 499 364,00